Jeffrey Stein - Mar 31, 2022 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role: President & CEO, Director
Signature: /s/ Jeffrey Stein
Stock symbol: CDTX
Transactions as of: Mar 31, 2022
Transactions value $: -$117,018
Form type: 4
Date filed: 4/4/2022, 05:09 PM
Previous filing: Feb 18, 2022
Next filing: Jun 10, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CDTX	Common Stock	Award	$0	+165K	+33.68%	$0.00	655K	Mar 31, 2022	Direct	F1
transaction	CDTX	Common Stock	Award	$0	+409K	+62.41%	$0.00	1.06M	Mar 31, 2022	Direct	F2
transaction	CDTX	Common Stock	Tax liability	-$117K	-141K	-13.26%	$0.83	923K	Mar 31, 2022	Direct	F3
holding	CDTX	Common Stock						232K	Mar 31, 2022	By trust
holding	CDTX	Common Stock						42K	Mar 31, 2022	By son

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CDTX	Employee Stock Option (right to buy)	Award	$0	+330K		$0.00	330K	Mar 31, 2022	Common Stock	330K	$0.83	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents time-based Restricted Stock Units (RSUs) granted on March 31, 2022. All RSUs vest in three equal annual installments, with 1/3 vesting on each of March 10, 2023, 2024, and 2025, subject to continuous service through each such vesting date.
F2	Represents RSUs granted on March 31, 2022. All RSUs are fully vested as of the grant date.
F3	Shares withheld for taxes on RSU vesting.
F4	The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 31, 2022.